Ultra-Long Peripheral Catheter Versus Accelerated Seldinger Technique Long Peripheral Catheter in Difficult IV Access Patients (ULAST)

University Ghent

Status: Begins enrollment this month

Conditions: Difficult Intravenous Access; Adults

Treatments: Device: Introcan safety deep access; Device: Powerglide pro™

Study type: Interventional

Funder types: Other

Identifiers

NCT07005310

ONZ-2024-0303

Details and patient eligibility

About

The aim of this study is to perform a comparative analysis of clinical outcomes associated with the use of an ultra-long peripheral catheter using (catheter-over-the-needle technique) versus an AST-long peripheral catheter in adult patients with difficult intravenous access (DIVA) in a real-world clinical setting. Specifically, the study will assess potential benefits, including longer mean catheter dwell time and improved catheter usability, as well as potential harms, such as increased incidence of catheter-related thrombosis, infections, phlebitis, infiltration, and unplanned catheter removal.

Enrollment: 100 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Adult inpatients with DIVA, requiring placement of a long peripheral catheter, will be included in the study.
• A digital request form for venous access must be completed by the treating physician at the ward.
• Patients must be proficient in either Dutch or French
• Patients must have decision-making capacity or be represented by a legal representative.

Exclusion criteria

• Expected therapy duration of less than 24 hours
• pregnancy
• Need for central venous access
• Inability to locate a deep peripheral vein in the upper extremity prior enrollment in the study
• Veins located deeper than 1.6cm prior enrollment in the study
• withdrawal of consent, or presentation at a time when study personnel are unavailable.

Trial design

Primary purpose: Diagnostic

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)

---

100 participants in 2 patient groups

Accelerated seldinger technique LPC

Active Comparator group

Description:

One study arm will be assigned the AST-long peripheral catheter (Powerglide Pro long peripheral catheter, BD) available in 18G 100 mm, 20G 100 mm (approx. 3.94 inches) and 22G 80 mm (approx. 3.15 inches).

Treatment:

Device: Powerglide pro™

Ultra-long peripheral catheter

Experimental group

Description:

The other study arm will be assigned the ultralong peripheral catheter (Introcan Safety deep access catheter, B. Braun) available in 18, 20 and 22G and 63.5 mm (approx. 2.5 inches) in length.

Treatment:

Device: Introcan safety deep access